Are the products inspected before shipping?

Yes, 100% inspection including visual and functional checks is performed on finished products.

Is the raw material traceable?

Yes, we maintain full traceability of all raw materials.

What certifications does the company hold?

The company holds ISO9001:2015 management system certification.

Ivd Analyzer Reagents Lyc1 Lyse for Dymind Df Series Hematology Analyzer

Name: Ivd Analyzer Reagents Lyc1 Lyse for Dymind Df Series Hematology Analyzer
Brand: Zhejiang Xinke Medical Technology Co., Ltd.
SKU: 2156155985

Zhejiang, ChinaZhejiang Xinke Medical Technology Co., Ltd.

US$1.00

1 Piece

Sample price:US$1.00/piece.Request sample

Product profile

Customization

Available

Type

IVD Reagent

Compatible Models

Sysmex Hematology Series

Transport Package

Carton

Specification

200

Trademark

xinke

Origin

China

HS Code

3822190090

Production Capacity

500000/Ctns

Key features

Compatible with Sysmex Series: Specifically designed for Sysmex Hematology Series analyzers.

OEM Service Available: Flexible customization options for OEM requirements.

ISO9001:2015 Certified: Manufacturing process certified under ISO9001:2015 standards.

100% Finished Product Inspection: Every unit undergoes visual and functional inspection.

Traceable Raw Materials: Full traceability system implemented for all raw materials.

16 R&D Engineers: Dedicated team of 16 engineers for product development.

Multiple Payment Terms: Accepts LC, T/T, D/P, PayPal, Western Union, and small payments.

Fast Lead Time: Production completed within 15 workdays for both peak and off-peak seasons.

Company profile

Importers and ExportersYears of Export Experience

Zhejiang Xinke Medical Technology Co., Ltd.

Zhejiang, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: OEM Service Available CertifiedCustomization Options: Flexible customization CertifiedExport Year: 20 Years CertifiedNearest Port: Ningbo PortAverage Response Time: ≤2.78h

AI-Powered supplier vetting

SummaryThe supplier operates in the clinical in vitro diagnostic reagent field and reports ten years of ISO9001 and ISO13485 quality-system certification. It offers flexible customization, has OEM experience with well-known brands, possesses self-managed import/export rights, and has exported for 20 years, with exports representing 51%–70% of total sales. Quality inspection procedures are documented and consistently followed, while stated lead times are within 15 working days in both peak and off-season. However, the supplier reports no inventory, overseas warehouse, overseas showroom, overseas agents or branches, offline trade-show participation, ODM service, SDK, recent new-product development, ERP, OA, CRM, SAP, or broader digitalization initiatives. Financial information is inconsistent or insufficiently interpretable in the provided records, so financial credibility cannot be determined.

Supplier typeThe supplier identifies itself as a company in the clinical in vitro diagnostic reagent field and has self-managed import/export rights with 20 years of export experience. This supports classification as an export-capable manufacturer or supplier in the medical in vitro diagnostics sector.

CertificationsThe company states that it has maintained ISO9001 and ISO13485 quality-system certifications for ten years. These explicitly documented certifications support a positive assessment of its quality-system credentials.

R&D capabilityThe supplier reports no new products in the past year, no ODM service, no available SDK, and no current enterprise digitalization or technical-transformation plan. These explicit limitations indicate weak demonstrated innovation capability.

Customization capabilityThe supplier explicitly provides flexible customization through both its R&D and design-service capabilities. This directly supports a positive assessment of customization capability, although ODM service is not offered.

Client casesThe supplier states that it provides OEM services for well-known brands, which is evidence of relevant customer experience. No specific brand names, project details, or verifiable case descriptions are provided, so the evidence is positive but limited.